Results 31 to 40 of about 1,790 (125)

Pharmacodynamics study of remimazolam besylate in anxious patients undergoing gastroscopy: a biased-coin design up-and-down sequential allocation trial [PDF]

BMC Anesthesiology
Background This study aimed to evaluate the impact of anxiety on the pharmacodynamics of remimazolam besylate in patients undergoing gastroscopy. Methods Patients undergoing gastroscopy were divided into two groups: an anxiety group (Self -rating Anxiety
Bao-Zhu Cha, Shuang-Yan Hu, Nian-Ping Chen, Jia-Fei Cao, Cheng Xu, Kai Qiu, Foquan Luo   +6 more
doaj   +2 more sources

Remimazolam besylate reduces hypoxemia during painless gastrointestinal endoscopy in elderly patients: study protocol for a multicenter, randomized, controlled trial [PDF]

Trials
Background Hypoxemia and circulatory depression are common complications in elderly patients undergoing procedure sedation anesthesia (PSA) for gastrointestinal (GI) endoscopy.
Fang-Yu Zhang, Zhe Ma, Wei Zhang, Zhi-Feng Gao, Li-Xin An   +4 more
doaj   +2 more sources

Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [PDF]

Drug Design, Development and Therapy, 2022
Yang Deng,1 Zhijun Qin,1 Qianyun Wu,2 Linsong Liu,1 Xi Yang,1 Xuan Ju,1 Ying Zhang,1 Lei Liu3 1Intensive Care Unit, Sichuan Provincial Orthopedic Hospital, Chengdu, 610041, People’s Republic of China; 2Nursing Department, Sichuan Provincial ...
Deng Y, Qin Z, Wu Q, Liu L, Yang X, Ju X, Zhang Y, Liu L   +7 more
doaj   +2 more sources

Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test—A Case Report and Literature Review

Medicina, 2023
Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test.
Sangho Lee, Joyoung Park, Na Hei Kim, Halin Hong, Kyoung Hee Sohn, Hee Yong Kang, Mi Kyeong Kim, Ann Hee You   +7 more
doaj   +2 more sources

Study of remimazolam besylate for general anaesthesia and population pharmacokinetics–pharmacodynamics in elderly, hepatic or renal-insufficient patients: a protocol for a multicentre randomised controlled trial in China [PDF]

BMJ Open
Background Remimazolam, an ultra-short-acting benzodiazepine, is characterised by rapid onset and recovery, metabolism independent of hepatic or renal function and haemostability.
Min Zhu, Guo Chen, Qinqin Yin, Tao Zhu, Miaomiao Tang   +4 more
doaj   +2 more sources

Effects of different doses of remimazolam on the quality of sedation and cardiac function in elderly patients: a double-blind randomised controlled study

Frontiers in Cardiovascular Medicine
BackgroundWe intended to observe the effects of different doses of remimazolam besylate via intravenous induction on the quality of sedation and cardiac function in elderly patients.MethodsA total of 135 ASA I–III patients undergoing elective ...
Liu Minghong, Qizhu Feng, Huichun Chen, Ju Li, Jun Shi   +4 more
doaj   +2 more sources

Efficacy of Remimazolam besylate for intravenous sedation in dental procedures for patients with cognitive disabilities: a prospective single-arm observational study [PDF]

BMC Oral Health
Objectives To assess the efficacy and safety of intravenous remimazolam besylate for sedation during dental procedures in patients with cognitive disabilities, a group frequently managed under general anesthesia due to poor cooperation and increased ...
Giovanni Battista Grossi, Gregorio Menozzi, Matteo Pellegrini, Marco Carraro, Laura Rey, Angela Galeotti, Andrea Scribante, Anna Papaleo, Giuseppe Sofi   +8 more
doaj   +2 more sources

Age‑stratified median effective dose (ED₅₀) of remimazolam besylate for successful gastroscope insertion without body movement in geriatric patients [PDF]

BMC Anesthesiology
Background Remimazolam besylate is increasingly used for procedure sedation anesthesia (PSA) in gastrointestinal endoscopy, but age‑specific dosing for elderly patients is unclear.
Si-Qi Hao, Zhe Ma, Fang-Yu Zhang, Yi-Xin Hu, Li-Xin An   +4 more
doaj   +2 more sources

Remimazolam induced cytotoxicity mediated through multiple stress pathways and acted synergistically with tyrosine kinase inhibitors in hepatocellular carcinoma

Redox Report
Objectives: The primary treatment for hepatocellular carcinoma (HCC) involves surgical removal of the primary tumor, but this creates a favorable environment for the proliferation and spread of residual and circulating cancer cells.
Hsiu-Lung Fan, Jia-Lin Chen, Shu-Ting Liu, Jia-Tong Lee, Shih-Ming Huang, Zhi-Fu Wu, Hou-Chuan Lai   +6 more
doaj   +2 more sources

The effects of remimazolam combined with sufentanil on respiration, circulation and sedation level in patients undergoing colonoscopy

BMC Anesthesiology
Background The main sedative which is propofol in painless gastroenteroscopy, has a high risk of reducing blood pressure and respiratory depression. Remimazolam (a short-acting benzodiazepine) is expected to be widely used in painless gastroenteroscopy ...
Qirui Sun, Jiating Cheng, Weiping Lei, Xinlei Lu, Yaqin Huang, Jianliang Sun   +5 more
doaj   +2 more sources